About
Kakkis earned a B.A. in biology from Pomona College and a combined M.D. and Ph.D. through the Medical Scientist Training Program at the UCLA School of Medicine. From September 1998 to February 2009 he held executive positions at BioMarin Pharmaceutical, ending as Chief Medical Officer, and he consulted for BioMarin from 2009 to 2010. He is board certified in medical genetics. Other biotech and pharmaceutical chief executives with pages on Whoo include Michael Morrissey of Exelixis and Samarth Kulkarni of CRISPR Therapeutics.
Kakkis founded the nonprofit EveryLife Foundation for Rare Diseases in 2009. He also served as interim principal financial officer of Ultragenyx from November 2022 until October 2023.
Whoo compiled this page from public sources: Ultragenyx 2026 proxy statement (SEC), Ultragenyx Q3 2026 results filing (SEC), Wikipedia: Emil Kakkis. It is not affiliated with or endorsed by Emil Kakkis. Are you Emil Kakkis? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Founder, President and Chief Executive Officer — Ultragenyx Pharmaceutical
April 2010 – Present | Novato, California
- Director since 2010
- Interim principal financial officer from November 2022 to October 2023
- Consulted for BioMarin from 2009 to 2010
Founder — EveryLife Foundation for Rare Diseases
2009 – Present
Chief Medical Officer and other executive roles — BioMarin Pharmaceutical
September 1998 – February 2009